>

RESEARCH

The role of inflammation in health and disease has been debated since the middle of the 19th century.  The focus of our research at TherimuneX™ stands upon the seminal work of the late Prof. Jurg Tschopp and the discovery of the inflammasome signaling platform.  We have extended this work and related inflammasome signaling to endoplasmic reticulum (ER) stress, the unfolded protein response (UPR), and the genesis and progression of chronic diseases.

PRODUCTS

Our research is focusing on elucidating the signaling pathways leading from cellular injury or infection and the innate immune response to either resolution of the injurious event or progression to disease.  This line of investigation has already led to a new therapeutic strategy to resolve acute and chronic infections and has most recently revealed an entirely new therapeutic rationale for the treatment of chronic diseases including cancer and the rare fibrotic disease, Scleroderma.

Platform for Fibrosis

Platform for Infectious Disease

get in touch

TherimuneX Pharmaceuticals

5110 Campus Drive

Plymouth Meting, PA 19462

 

610-233-0333

 

 

info@therimunex.com

 

 

 

The Inflammasome

Our research is focusing on elucidating the signaling pathways leading from cellular injury or infection and the innate immune response to either resolution of the injurious event or progession to disease.  This line of investigation has already led to a new therapeutic strategy to resolve acute and chronic infections and has most recently revealed an entirely new therapeutic rationale for the treatment of chronic diseases including cancer and the rare fibrotic disease, Scleroderma.

 

about our company

TherimuneX™ is a bio-pharmaceutical research and development company. The mission of the Company is to fully exploit the commercial applications of a new medical discovery by Dr. James D. Thacker, PhD.

R Mechanism focused research
R Genesis and progression of chronic diseases
R Inflammasome signaling platform
R Endoplasmic reticulum (ER) stress, the unfolded protein response (UPR)

 

© 2014 Therimunex. All Rights Reserved.